256 related articles for article (PubMed ID: 25637785)
1. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma.
Kim BK; Kim SU; Kim KA; Chung YE; Kim MJ; Park MS; Park JY; Kim DY; Ahn SH; Kim MD; Park SI; Won JY; Lee DY; Han KH
J Hepatol; 2015 Jun; 62(6):1304-10. PubMed ID: 25637785
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of the Initial and Best Responses after Chemoembolization in the Treatment of Intermediate-Stage Hepatocellular Carcinoma with Preserved Liver Function.
Park C; Chu HH; Kim JH; Kim SY; Alrashidi I; Gwon DI; Yoon HK; Kim N
J Vasc Interv Radiol; 2020 Dec; 31(12):1998-2006.e1. PubMed ID: 32988715
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
5. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
[TBL] [Abstract][Full Text] [Related]
6. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
7. Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study.
Pinato DJ; Arizumi T; Jang JW; Allara E; Suppiah PI; Smirne C; Tait P; Pai M; Grossi G; Kim YW; Pirisi M; Kudo M; Sharma R
Oncotarget; 2016 Jul; 7(28):44705-44718. PubMed ID: 27244889
[TBL] [Abstract][Full Text] [Related]
8. The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series.
Terzi E; Terenzi L; Venerandi L; Croci L; Renzulli M; Mosconi C; Allegretti G; Granito A; Golfieri R; Bolondi L; Piscaglia F
Dig Dis; 2014; 32(6):711-6. PubMed ID: 25376288
[TBL] [Abstract][Full Text] [Related]
9. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
10. The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE.
Kim JH; Sinn DH; Shin SW; Cho SK; Kang W; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Choi MS
Clin Mol Hepatol; 2017 Mar; 23(1):42-50. PubMed ID: 28263954
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Lee JS; Chon YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kang W; Choi MS; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Kim HY; Kim TH; Yoo K; Ha Y; Kim MN; Lee JH; Hwang SG; Kim SS; Cho HJ; Cheong JY; Cho SW; Park SH; Heo NY; Hong YM; Yoon KT; Cho M; Park JG; Kang MK; Park SY; Kweon YO; Tak WY; Jang SY; Sinn DH; Kim SU;
Yonsei Med J; 2021 Jan; 62(1):12-20. PubMed ID: 33381930
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.
Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM
J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099
[TBL] [Abstract][Full Text] [Related]
13. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
Shin BS; Park MH; Jeon GS
Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
[TBL] [Abstract][Full Text] [Related]
14. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.
Manini MA; Sangiovanni A; Martinetti L; Viganò D; La Mura V; Aghemo A; Iavarone M; Crespi S; Nicolini A; Colombo M
Liver Transpl; 2015 Oct; 21(10):1259-69. PubMed ID: 26074360
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization Followed by Radiotherapy Versus Sandwich Treatment for Unresectable or Ablative Hepatocellular Carcinoma.
Lin H; Wu H; Cong N; Liu B; Liu C; Han D
Technol Cancer Res Treat; 2020; 19():1533033820983799. PubMed ID: 33357168
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.
Chung JW; Park JH; Han JK; Choi BI; Han MC
AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547
[TBL] [Abstract][Full Text] [Related]
18. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study.
Yu JI; Park JW; Park HC; Yoon SM; Lim DH; Lee JH; Lee HC; Kim SW; Kim JH
Radiother Oncol; 2016 Feb; 118(2):408-15. PubMed ID: 26830695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
